PTEN and prostate carcinoma: For example in mouse models, heterozygosity for PTEN leads to massively increased susceptibility to multiple tumor types [65–67], increased cell proliferation in the thyroid and prostate gland [65], and has been shown to cooperate with other genetic events, such as ERG fusion in murine prostate cancer [68, 69].